1. Home
  2. RVPHW vs GPRO Comparison

RVPHW vs GPRO Comparison

Compare RVPHW & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPHW
  • GPRO
  • Stock Information
  • Founded
  • RVPHW 2018
  • GPRO 2004
  • Country
  • RVPHW United States
  • GPRO United States
  • Employees
  • RVPHW 14
  • GPRO N/A
  • Industry
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • GPRO Industrial Machinery/Components
  • Sector
  • RVPHW Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • RVPHW Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • RVPHW N/A
  • GPRO 118.4M
  • IPO Year
  • RVPHW N/A
  • GPRO 2014
  • Fundamental
  • Price
  • RVPHW $0.04
  • GPRO $0.78
  • Analyst Decision
  • RVPHW
  • GPRO Hold
  • Analyst Count
  • RVPHW 0
  • GPRO 1
  • Target Price
  • RVPHW N/A
  • GPRO $1.50
  • AVG Volume (30 Days)
  • RVPHW 22.4K
  • GPRO 4.0M
  • Earning Date
  • RVPHW 03-14-2025
  • GPRO 08-05-2025
  • Dividend Yield
  • RVPHW N/A
  • GPRO N/A
  • EPS Growth
  • RVPHW N/A
  • GPRO N/A
  • EPS
  • RVPHW N/A
  • GPRO N/A
  • Revenue
  • RVPHW N/A
  • GPRO $780,312,000.00
  • Revenue This Year
  • RVPHW N/A
  • GPRO N/A
  • Revenue Next Year
  • RVPHW N/A
  • GPRO $6.79
  • P/E Ratio
  • RVPHW N/A
  • GPRO N/A
  • Revenue Growth
  • RVPHW N/A
  • GPRO N/A
  • 52 Week Low
  • RVPHW $0.13
  • GPRO $0.40
  • 52 Week High
  • RVPHW $0.15
  • GPRO $1.76
  • Technical
  • Relative Strength Index (RSI)
  • RVPHW N/A
  • GPRO 52.26
  • Support Level
  • RVPHW N/A
  • GPRO $0.72
  • Resistance Level
  • RVPHW N/A
  • GPRO $0.81
  • Average True Range (ATR)
  • RVPHW 0.00
  • GPRO 0.05
  • MACD
  • RVPHW 0.00
  • GPRO -0.01
  • Stochastic Oscillator
  • RVPHW 0.00
  • GPRO 41.06

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: